Thrivent Financial for Lutherans
CME icon

Thrivent Financial for Lutherans’s CME Group CME Stock Holding History

Thrivent Financial for Lutherans’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.75M Buy
16,066
+560
+4% +$166K 0.01% 933
2025
Q4 		$4.24M Sell
15,506
-173
-1% -$47K 0.01% 1014
2025
Q3 		$4.24M Sell
15,679
-22,340
-59% -$6.08M 0.01% 908
2025
Q2 		$10.5M Buy
38,019
+22,046
+138% +$6M 0.02% 543
2025
Q1 		$4.24M Buy
15,973
+10
+0.1% +$2.47K 0.01% 894
2024
Q4 		$3.71M Sell
15,963
-873
-5% -$201K 0.01% 1050
2024
Q3 		$3.71M Sell
16,836
-4,008
-19% -$829K 0.01% 1073
2024
Q2 		$4.1M Sell
20,844
-655
-3% -$135K 0.01% 974
2024
Q1 		$4.63M Sell
21,499
-18,544
-46% -$3.9M 0.01% 921
2023
Q4 		$8.43M Sell
40,043
-18,756
-32% -$4M 0.02% 690
2023
Q3 		$11.8M Sell
58,799
-38,274
-39% -$7.61M 0.03% 560
2023
Q2 		$18M Sell
97,073
-6,201
-6% -$1.15M 0.04% 449
2023
Q1 		$19.8M Buy
103,274
+87,206
+543% +$15.8M 0.05% 421
2022
Q4 		$2.7M Buy
16,068
+75
+0.5% +$13K 0.01% 1065
2022
Q3 		$2.83M Buy
15,993
+152
+1% +$30K 0.01% 1015
2022
Q2 		$3.24M Buy
15,841
+52
+0.3% +$11K 0.01% 977
2022
Q1 		$3.76M Sell
15,789
-1,834
-10% -$431K 0.01% 995
2021
Q4 		$4.03M Sell
17,623
-153,311
-90% -$33.7M 0.01% 991
2021
Q3 		$33.1M Buy
170,934
+23,413
+16% +$4.74M 0.07% 325
2021
Q2 		$31.4M Buy
147,521
+6,836
+5% +$1.44M 0.06% 347
2021
Q1 		$28.7M Buy
140,685
+18,370
+15% +$3.62M 0.06% 351
2020
Q4 		$22.3M Buy
122,315
+63,992
+110% +$10.9M 0.05% 419
2020
Q3 		$9.76M Sell
58,323
-68,395
-54% -$11.5M 0.03% 606
2020
Q2 		$20.6M Sell
126,718
-18,061
-12% -$3.24M 0.06% 356
2020
Q1 		$25M Buy
144,779
+127,055
+717% +$25.3M 0.09% 268
2019
Q4 		$3.56M Buy
17,724
+51
+0.3% +$10.5K 0.01% 805
2019
Q3 		$3.73M Buy
17,673
+428
+2% +$89.4K 0.01% 753
2019
Q2 		$3.35M Buy
17,245
+1,277
+8% +$235K 0.01% 791
2019
Q1 		$2.63M Buy
15,968
+153
+1% +$27K 0.01% 845
2018
Q4 		$2.98M Buy
15,815
+1,194
+8% +$220K 0.01% 732
2018
Q3 		$2.49M Buy
14,621
+323
+2% +$54.4K 0.01% 821
2018
Q2 		$2.34M Buy
14,298
+97
+0.7% +$15.8K 0.01% 847
2018
Q1 		$2.3M Buy
14,201
+377
+3% +$60K 0.01% 847
2017
Q4 		$2.02M Buy
13,824
+261
+2% +$37.2K 0.01% 912
2017
Q3 		$1.84M Buy
13,563
+703
+5% +$88.8K 0.01% 896
2017
Q2 		$1.61M Buy
12,860
+360
+3% +$43.1K 0.01% 899
2017
Q1 		$1.49M Buy
12,500
+660
+6% +$79.4K 0.01% 970
2016
Q4 		$1.37M Buy
11,840
+720
+6% +$80.1K 0.01% 1003
2016
Q3 		$1.16M Buy
11,120
+660
+6% +$68.9K 0.01% 1073
2016
Q2 		$1.02M Buy
10,460
+530
+5% +$50.1K ﹤0.01% 1090
2016
Q1 		$954K Buy
9,930
+390
+4% +$35.5K ﹤0.01% 1095
2015
Q4 		$864K Buy
9,540
+290
+3% +$27.3K ﹤0.01% 1117
2015
Q3 		$858K Buy
9,250
+1,000
+12% +$95.1K ﹤0.01% 1003
2015
Q2 		$768K Buy
8,250
+400
+5% +$37.3K ﹤0.01% 915
2015
Q1 		$743K Buy
7,850
+400
+5% +$37.1K ﹤0.01% 944
2014
Q4 		$660K Buy
7,450
+50
+0.7% +$4.24K ﹤0.01% 980
2014
Q3 		$592K Sell
7,400
-50
-0.7% -$3.77K ﹤0.01% 1031
2014
Q2 		$529K Buy
7,450
+50
+0.7% +$3.52K ﹤0.01% 1103
2014
Q1 		$548K Buy
7,400
+100
+1% +$7.54K ﹤0.01% 919
2013
Q4 		$573K Hold
7,300
– – ﹤0.01% 935
2013
Q3 		$539K Sell
7,300
-3,200
-30% -$236K ﹤0.01% 895
2013
Q2 		$797 Buy
+10,500
New +$689K 0.01% 754

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Thrivent Financial for Lutherans's CME Position: Q1 2026 in Review

Thrivent Financial for Lutherans increased its CME Group (CME) stake by 3.6% in Q1 2026, buying an estimated $166K and bringing the position to 16,066 shares worth $4.75M. The position accounts for 0.01% of the portfolio, ranked #933.

Thrivent Financial for Lutherans first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $33.1M in Q3 2021. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Thrivent Financial for Lutherans held 16,066 shares of CME Group worth $4.75M as of Q1 2026.
  • Thrivent Financial for Lutherans bought 560 CME Group shares in Q1 2026, an estimated $166K.
  • CME Group made up 0.01% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #933 holding.
  • Thrivent Financial for Lutherans first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • Thrivent Financial for Lutherans's CME Group position peaked at $33.1M in Q3 2021.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.